An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters

Psychopharmacology

Volumn 200, Issue 3, 2008, Pages 333-346

  Moise, Anna M ^a   Eisenstein, Sarah A ^a   Astarita, Giuseppe ^b   Piomelli, Daniele ^b   Hohmann, Andrea G ^a  

^a University of Georgia ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Cannabinoids; Conditioned defeat; Elevated plus maze; FAAH; Social defeat

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; BENZODIAZEPINE DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR AGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DIAZEPAM; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; RIMONABANT;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; ATAXIA; AUTORADIOGRAPHY; CONDITIONED DEFEAT; CONDITIONING; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DRUG ANTAGONISM; DRUG BINDING SITE; DRUG MEGADOSE; DRUG RECEPTOR BINDING; HYDROLYSIS; IC 50; LIPID BRAIN LEVEL; LIQUID CHROMATOGRAPHY; LOCOMOTION; LOW DRUG DOSE; MALE; MASS SPECTROMETRY; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; SOCIAL DEFEAT; SYRIAN HAMSTER; TRANQUILIZING ACTIVITY;

AGGRESSION; AMIDOHYDROLASES; ANIMALS; AROUSAL; AUTORADIOGRAPHY; BENZAMIDES; BRAIN; CARBAMATES; CRICETINAE; DOMINANCE-SUBORDINATION; ENDOCANNABINOIDS; ETHANOLAMINES; FEAR; MALE; MAZE LEARNING; MESOCRICETUS; PALMITIC ACIDS; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; ROTAROD PERFORMANCE TEST; SIGNAL TRANSDUCTION; SOCIAL ENVIRONMENT;

EID: 51849139922     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1209-5     Document Type: Article

References (52)

1. BE Akinshola A Chakrabarti ES Onaivi 1999 In-vitro and in-vivo action of cannabinoids Neurochem Res 24 1233 1240
2. C Arevalo R de Miguel R Hernandez-Tristan 2001 Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters Pharmacol Biochem Behav 70 123 131
3. SC Azad M Eder G Marsicano B Lutz W Zieglgansberger G Rammes 2003 Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse Learn Mem 10 116 128
4. S Ben-Shabat E Fride T Sheskin T Tamiri MH Rhee Z Vogel T Bisogno L De Petrocellis V Di Marzo R Mechoulam 1998 An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity Eur J Pharmacol 353 23 31
5. M Bortolato RA Mangieri J Fu JH Kim O Arguello A Duranti A Tontini M Mor G Tarzia D Piomelli 2007 Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress Biol Psychiatry 62 1103 1110
6. AP Carobrez LJ Bertoglio 2005 Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on Neurosci Biobehav Rev 29 1193 205
7. DR Compton KC Rice BR De Costa RK Razdan LS Melvin MR Johnson BR Martin 1993 Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities J Pharmacol Exp Ther 265 218 226
8. BF Cravatt DK Giang SP Mayfield DL Boger RA Lerner NB Gilula 1996 Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 83 87
9. BF Cravatt K Demarest MP Patricelli MH Bracey DK Giang BR Martin AH Lichtman 2001 Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc Natl Acad Sci U S A 98 9371 9376
10. L Degenhardt W Hall M Lynskey 2001 The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being Soc Psychiatry Psychiatr Epidemiol 36 219 227
11. F Desarnaud H Cadas D Piomelli 1995 Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization J Biol Chem 270 6030 6035
12. D Fegley S Gaetani A Duranti A Tontini M Mor G Tarzia D Piomelli 2005 Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation J Pharmacol Exp Ther 313 352 358
13. A Giuffrida F Rodriguez de Fonseca D Piomelli 2000 Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry Anal Biochem 280 87 93
14. G Griebel J Stemmelin B Scatton 2005 Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents Biol Psychiatry 57 261 267
15. J Haller N Bakos M Szirmay C Ledent TF Freund 2002 The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety Eur J Neurosci 16 1395 1398
16. J Haller B Varga C Ledent I Barna TF Freund 2004 Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice Eur J Neurosci 19 1906 1912
17. J Haller B Varga C Ledent TF Freund 2004 CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents Behav Pharmacol 15 299 304
18. MA Hebert M Potegal T Moore AR Evenson JL Meyerhoff 1996 Diazepam enhances conditioned defeat in hamsters (Mesocricetus auratus) Pharmacol Biochem Behav 55 405 413
19. M Herkenham AB Lynn MR Johnson LS Melvin BR de Costa KC Rice 1991 Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 11 563 583
20. CJ Hillard A Jarrahian 2005 Accumulation of anandamide: evidence for cellular diversity Neuropharmacology 48 1072 1078
21. S Hogg 1996 A review of the validity and variability of the elevated plus-maze as an animal model of anxiety Pharmacol Biochem Behav 54 21 30
22. AG Hohmann M Herkenham 1998 Regulation of cannabinoid and mu opioid receptor binding sites following neonatal capsaicin treatment Neurosci Lett 252 13 16
23. AG Hohmann RL Suplita NM Bolton MH Neely D Fegley R Mangieri JF Krey JM Walker PV Holmes JD Crystal A Duranti A Tontini M Mor G Tarzia D Piomelli 2005 An endocannabinoid mechanism for stress-induced analgesia Nature 435 1108 1112
24. AG Hohmann EM Briley M Herkenham 1999 Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord Brain Res 822 17 25
25. AM Jasnow KL Huhman 2001 Activation of GABA(A) receptors in the amygdala blocks the acquisition and expression of conditioned defeat in Syrian hamsters Brain Res 920 142 150
26. AM Jasnow MC Banks EC Owens KL Huhman 1999 Differential effects of two corticotropin-releasing factor antagonists on conditioned defeat in male Syrian hamsters (Mesocricetus auratus) Brain Res 846 122 128
27. AM Jasnow C Shi JE Israel M Davis KL Huhman 2005 Memory of social defeat is facilitated by cAMP response element-binding protein overexpression in the amygdala Behav Neurosci 119 1125 1130
28. N Jones SM King MS Duxon 2002 Further evidence for the predictive validity of the unstable elevated exposed plus-maze, a behavioural model of extreme anxiety in rats: differential effects of fluoxetine and chlordiazepoxide Behav Pharmacol 13 525 535
29. S Kathuria S Gaetani D Fegley F Valino A Duranti A Tontini M Mor G Tarzia G La Rana A Calignano A Giustino M Tattoli M Palmery V Cuomo D Piomelli 2003 Modulation of anxiety through blockade of anandamide hydrolysis Nat Med 9 76 81
30. Kreiskott H (1963) Zur Verhaltungsforschung im Rahmen der Psychopharmakologie. Medizin und Chemie, 7:177
31. M Maccarrone O Valverde ML Barbaccia A Castaänâe R Maldonado C Ledent M Parmentier A Finazzi-Agráo 2002 Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour Eur J Neurosci 15 1178 1186
32. G Marsicano B Lutz 1999 Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain Eur J Neurosci 11 4213 4225
33. G Marsicano CT Wotjak SC Azad T Bisogno G Rammes MG Cascio H Hermann J Tang C Hofmann W Zieglgansberger V Di Marzo B Lutz 2002 The endogenous cannabinoid system controls extinction of aversive memories Nature 418 530 534
34. FA Moreira DC Aguiar FS Guimaraes 2006 Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test Prog Neuro-psychopharmacol Biol Psychiatry 30 1466 1471
35. FA Moreira N Kaiser K Monory B Lutz 2008 Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid- degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors Neuropharmacology 54 141 150
36. N Naderi A Haghparast A Saber-Tehrani N Rezaii AM Alizadeh A Khani F Motamedi 2008 Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice Pharmacol Biochem Behav 89 64 75
37. Ognibene E, Adriani W, Laviola G (2006) Anxiolytic and reward-related properties of URB597, a novel FAAH inhibitor, in CD1 mice. Anxiety disorders and anxiolytics-anxiety disorders (basic): S460
38. ES Onaivi MR Green BR Martin 1990 Pharmacological characterization of cannabinoids in the elevated plus maze J Pharmacol Exp Ther 253 1002 1009
39. S Patel CJ Hillard 2006 Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling J Pharmacol Exp Ther 318 304 311
40. S Patel CT Roelke DJ Rademacher WE Cullinan CJ Hillard 2004 Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis Endocrinology 145 5431 5438
41. S Patel CT Roelke DJ Rademacher CJ Hillard 2005 Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling Eur J Neurosci 21 1057 1069
42. S Pellow P Chopin SE File M Briley 1985 Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 149 167
43. D Piomelli 2003 The molecular logic of endocannabinoid signalling Nat Rev Neurosci 4 873 884
44. D Piomelli G Tarzia A Duranti A Tontini M Mor TR Compton O Dasse EP Monoghan JA Parrott D Putman 2006 Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597) CNS Drug Rev 12 21 38
45. M Potegal K Huhman T Moore J Meyerhoff 1993 Conditioned defeat in the Syrian golden hamster (Mesocricetus auratus) Behav Neural Biol 60 93 102
46. M Scherma J Medalie W Fratta SK Vadivel A Makriyannis D Piomelli E Mikics J Haller S Yasar G Tanda SR Goldberg 2007 The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition Neuropharmacology 54 129 140
47. RL Suplita 2nd SA Eisenstein MH Neely AM Moise AG Hohmann 2008 Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia Neuropharmacology 54 161 171
48. D Treit JP Pinel HC Fibiger 1981 Conditioned defensive burying: a new paradigm for the study of anxiolytic agents Pharmacol Biochem Behav 15 619 626
49. O Valverde C Ledent F Beslot M Parmentier BP Roques 2000 Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors Eur J Neurosci 12 533 539
50. S Walfish R Massey A Krone 1990 Anxiety and anger among abusers of different substances Drug Alcohol Depend 25 253 256
51. PC Yannielli BI Kanterewicz DP Cardinali 1996 Daily rhythms in spontaneous and diazepam-induced anxiolysis in Syrian hamsters Pharmacol Biochem Behav 54 651 656
52. LJ Young 2002 The neurobiology of social recognition, approach, and avoidance Biol Psychiatry 51 18 26